Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-12 4:30 pm Sale | 2024-12-31 | 13G | CAVA Group, Inc. CAVA | Artal Participations S.a r.l | 9,507,990 8.300% | -8,000,000![]() (-45.69%) | Filing History |
2024-11-12 4:32 pm Sale | 2024-09-30 | 13G | CAVA Group, Inc. CAVA | Artal Participations S.a r.l | 17,507,990 15.300% | -14,500,000![]() (-45.30%) | Filing History |
2024-07-12 6:23 pm Sale | 2024-07-12 | 13G | Korro Bio, Inc. KRRO | Artal Participations S.a r.l | 413,072 4.500% | -5,533![]() (-1.32%) | Filing History |
2024-07-12 6:17 pm Sale | 2024-07-12 | 13G | Cyclerion Therapeutics, Inc. CYCN | Artal Participations S.a r.l | 116,155 4.300% | -22,800![]() (-16.41%) | Filing History |
2024-07-12 6:12 pm Purchase | 2024-07-12 | 13G | Cartesian Therapeutics, Inc. RNAC | Artal Participations S.a r.l | 594,940 2.800% | 246,412![]() (+70.70%) | Filing History |
2024-07-08 6:51 pm Purchase | 2023-06-01 | 13G | HOOKIPA Pharma Inc. HOOK | Artal Participations S.a r.l | 566,641 5.900% | 466,142![]() (+463.83%) | Filing History |
2024-03-29 4:30 pm Sale | 2024-03-29 | 13G | Achilles Therapeutics plc ACHL | Artal Participations S.a r.l | 755,375 1.900% | -1,500,000![]() (-66.51%) | Filing History |
2024-03-29 4:30 pm Unchanged | 2024-03-29 | 13G | Vigil Neuroscience, Inc. VIGL | Artal Participations S.a r.l | 1,811,191 4.900% | 0 (Unchanged) | Filing History |
2024-02-09 5:16 pm Sale | 2023-12-31 | 13G | Aptinyx Inc. APTX | Artal Participations S.a r.l | 0 0.000% | -6,116,493![]() (Position Closed) | Filing History |
2024-02-09 5:14 pm Sale | 2023-12-31 | 13G | Aravive, Inc. ARAV | Artal Participations S.a r.l | 7,609,522 9.400% | -4,572,515![]() (-37.53%) | Filing History |
2024-02-09 5:14 pm Purchase | 2023-12-31 | 13G | Scholar Rock Holding Corporation SRRK | Artal Participations S.a r.l | 12,834,446 17.400% | 2,279,168![]() (+21.59%) | Filing History |
2024-02-09 5:13 pm Purchase | 2023-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC | Artal Participations S.a r.l | 348,528 6.400% | 8,295![]() (+2.44%) | Filing History |
2024-02-09 5:13 pm Sale | 2023-12-31 | 13G | Vigil Neuroscience, Inc. VIGL | Artal Participations S.a r.l | 1,811,191 5.000% | -432,161![]() (-19.26%) | Filing History |
2024-02-09 5:12 pm Purchase | 2023-12-31 | 13G | AlloVir, Inc. ALVR | Artal Participations S.a r.l | 286,833 5.800% | 44,348![]() (+18.29%) | Filing History |
2024-02-09 5:11 pm Purchase | 2023-12-31 | 13G | IGM Biosciences, Inc. IGMS | Artal Participations S.a r.l | 3,100,422 9.400% | 650,422![]() (+26.55%) | Filing History |
2024-02-09 5:11 pm Sale | 2023-12-31 | 13G | Agenus Inc. AGEN | Artal Participations S.a r.l | 781,562 4.100% | -14,850![]() (-1.86%) | Filing History |
2024-02-09 5:10 pm Purchase | 2023-12-31 | 13G | SQZ Biotechnologies Company SQZB | Artal Participations S.a r.l | 1,141,309 3.900% | 980,678![]() (+610.52%) | Filing History |
2024-02-09 5:09 pm Purchase | 2023-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | Artal Participations S.a r.l | 2,038,870 9.900% | 1,804,126![]() (+768.55%) | Filing History |
2024-02-09 5:08 pm Purchase | 2023-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Artal Participations S.a r.l | 3,568,842 9.900% | 2,105,013![]() (+143.80%) | Filing History |
2024-02-09 5:08 pm Sale | 2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM | Artal Participations S.a r.l | 0 0.000% | -15,066,043![]() (Position Closed) | Filing History |